Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus is a research paper published in The Journal of Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority
Grant: HHSO100201600023C
University of Maryland Baltimore
Grant: HHSO100201700020C
National Institutes of Health
Grant: HHSN272201500002C
National Institutes of Health
Grant: HHSN272201500005I
NIAID
Grant: R21-AI126300
NIAID
Grant: T32-AI095190
NIAID
Grant: F32-AI136390
National Institutes of Health
Grant: 2T32AI095190-06
Signaling Pathways in Innate Immunity
National Institutes of Health
Grant: 1F32AI136390-01A1
The role of diabetes in Middle East Respiratory Syndrome Coronavirus pathogenesis
National Institutes of Health
Grant: 1R21AI126300-01
Diabetic Comorbidity and MERS Coronavirus Pathogenesis
FWCI
0.43
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals